Cargando…
Scalable, Micro-Neutralization Assay for Qualitative Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic was expanding, it was clear that effective testing for the presence of neutralizing antibodies in the blood of convalescent patients would be critical for development of plasma-based therapeutic approaches. To address the n...
Autores principales: | Bennett, Richard S., Postnikova, Elena N., Liang, Janie, Gross, Robin, Mazur, Steven, Dixit, Saurabh, Lukin, Vladimir V., Kocher, Greg, Yu, Shuiqing, Georgia-Clark, Shalamar, Gerhardt, Dawn, Cai, Yingyun, Marron, Lindsay, Holbrook, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941633/ https://www.ncbi.nlm.nih.gov/pubmed/33688658 http://dx.doi.org/10.1101/2021.03.05.434152 |
Ejemplares similares
-
Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
por: Bennett, Richard S., et al.
Publicado: (2021) -
Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples
por: Postnikova, Elena N., et al.
Publicado: (2019) -
Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays
por: Caì, Yíngyún, et al.
Publicado: (2018) -
Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties
por: Bennett, Ryan P., et al.
Publicado: (2022) -
Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
por: Mohsen, Mona O., et al.
Publicado: (2021)